Publications Print Shehata M, Al Hosani I, Ahmed I, Abu Alkas H, Khaddam O, Aljanahi AA, Al Ahmad M, Al Tiniji K, Singh Y, Malik T. Factors Associated With Short-Term Complications After Percutaneous Endoscopic Gastrostomy Tube Insertion: A Retrospective Cohort Study. Cureus. 2024 Mar; 16 (3):e55741 Epub 2024 Mar 07 View PubMed Santiago P, Coelho-Prabhu N, Lennon R, Rui S, Rajauria P, Friton J, Raffals LE, Deepali F, Daoud N, Farraye FA, Tuck J, Malik T, Leleiko NS, Shapiro J, Shah SA, Sands BE, Ungaro RC. Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. Am J Gastroenterol. 2024 Jan 1; 119 (1):147-154 Epub 2023 Sept 15 View PubMed Santiago P, Coelho-Prabhu N, Lennon R, Rui S, Rajauria P, Friton J, Raffals LE, Deepali F, Daoud N, Farraye FA, Tuck J, Malik T, Leleiko NS, Shapiro J, Shah SA, Sands BE, Ungaro RC. Baseline clinical factors are associated with risk of complications in Crohn's disease: appraisal of the American Gastroenterological Association clinical care pathway. American Journal of Gastroenterology. 2024; 119 (1):147-54 Mahmoud AA, Abdelhay A, Khamis A, Mostafa M, Shehadah A, Mohamed MS, Eltaher B, Malik T. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis. Ann Hematol. 2023 Jul; 102 (7):1705-1711 Epub 2023 Apr 24 View PubMed Guerrero Vinsard D, Bruining DH, East JE, Ebner D, Kane SV, Kisiel JB, Leighton JA, Lennon RJ, Loftus EV Jr, Malik T, Picco M, Raffals L, Ramos GP, Santiago P, Coelho-Prabhu N. Interobserver agreement of the modified Paris classification and histology prediction of colorectal lesions in patients with inflammatory bowel disease. Gastrointest Endosc. 2023 Apr; 97 (4):790-798.e2 Epub 2022 Nov 17 View PubMed Saade MC, Wehbe H, Mourad FH, Hosni M, Francis FF, Makki M, Binion DG, Tamim H, Farraye FA, Malik T, Hashash JG. Significance of granulomas in the outcomes of Crohn's disease patients. Ann Gastroenterol. 2022 Sep-Oct; 35 (5):503-508 Epub 2022 July 11 View PubMed Cho JM, Loftus EV Jr, Bruining DH, Chedid VG, Farraye FA, Faubion WA Jr, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 Nov 1; 116 (11):2296-2299 View PubMed Ahmed Z, Lysek M, Zhang N, Malik TA. Association Between Serological Markers and Crohn's Disease Activity. J Clin Med Res. 2020 Jan; 12 (1):6-12 Epub 2020 Jan 06 View PubMed Ahmed Z, Venkata K, Zhang N, Malik TA. Comparative Effectiveness of Ustekinumab Versus Adalimumab in Induction of Clinical Response and Remission in Crohn's Disease: Experience of a Real-World Cohort at a Tertiary Care Inflammatory Bowel Disease Referral Center. Gastroenterology Res. 2019 Oct; 12 (5):245-251 Epub 2019 Oct 04 View PubMed Walker C, Allamneni C, Orr J, Yun H, Fitzmorris P, Xie F, Malik TA. Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn's Disease Patients. Sci Rep. 2018 Mar 5; 8 (1):4028 Epub 2018 Mar 05 View PubMed Allamneni C, Venkata K, Yun H, Xie F, DeLoach L, Malik TA. Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center. Gastroenterology Res. 2018 Feb; 11 (1):41-45 Epub 2018 Feb 23 View PubMed Walker CH, Arora SS, Colantonio LD, Kakati DD, Fitzmorris PS, Chu DI, Malik TA. Rates of hospitalization among African American and Caucasian American patients with Crohn's disease seen at a tertiary care center. Gastroenterol Rep (Oxf). 2017 Nov; 5 (4):288-292 Epub 2016 Dec 10 View PubMed Venkata KVR, Arora SS, Xie FL, Malik TA. Impact of vitamin D on the hospitalization rate of Crohn's disease patients seen at a tertiary care center. World J Gastroenterol. 2017 Apr 14; 23 (14):2539-2544 View PubMed Orr J, Venkata KV, Young S, Xie F, Malik TA. Budesonide Use and Hospitalization Rate in Crohn's Disease: Results From a Cohort at a Tertiary Care IBD Referral Center. J Clin Med Res. 2016 Oct; 8 (10):705-9 Epub 2016 Aug 30 View PubMed Gunnells DJ Jr, Morris MS, DeRussy A, Gullick AA, Malik TA, Cannon JA, Hawn MT, Chu DI. Racial Disparities in Readmissions for Patients with Inflammatory Bowel Disease (IBD) After Colorectal Surgery. J Gastrointest Surg. 2016 May; 20 (5):985-93 Epub 2016 Jan 07 View PubMed Manne A, Ahmed MB, Malik TA. Predictors of Outcome of Rectovaginal Fistula Surgery in Women With Crohn's Disease. J Clin Med Res. 2016 Feb; 8 (2):126-9 Epub 2015 Dec 28 View PubMed Manne A, Khan AS, Malik TA. Obesity and Outcome of Crohn's Associated Perianal Fistula Surgery: A Case-Control Study. Gastroenterology Res. 2015 Dec; 8 (6):291-295 Epub 2015 Dec 31 View PubMed Malik TA. Inflammatory Bowel Disease: Historical Perspective, Epidemiology, and Risk Factors. Surg Clin North Am. 2015 Dec; 95 (6):1105-22, v Epub 2015 Sept 07 View PubMed Fitzmorris PS, Colantonio LD, Torrazza Perez E, Smith I, Kakati DD, Malik TA. Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: a retrospective cohort study. Digestion. 2015; 91 (3):257-62 Epub 2015 Mar 31 View PubMed Malik TA, Kaslow RA, Cofield SS, Mannon PJ. Body Mass Index Is Associated With Mucosal Disease in Crohn's: Results of a Case-Control Study. Gastroenterology Res. 2014 Dec; 7 (5-6):111-117 Epub 2014 Dec 27 View PubMed Malik TA. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan; 146(1):85-95. Sandborn WJ, PURSUIT-Maintenence, Malik T. Subcutaneous Golimumab Maintains ClinicalResponse in Patients With Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2014 Jan; 146(1):96-109. Malik TA, Manne A, Oster RA, Eckhoff A, Inusah S, Gutierrez AM. Obesity is Associated With Poor Surgical Outcome in Crohn's Disease. Gastroenterology Res. 2013 Jun; 6 (3):85-90 Epub 2013 July 14 View PubMed Malik TA, Council L, Weber FH Jr. A most unusual passage per rectum. Gastroenterology. 2013 May; 144 (5):e3-4 Epub 2013 Mar 23 View PubMed Kiage JN, Merrill PD, Robinson CJ, Cao Y, Malik TA, Hundley BC, Lao P, Judd SE, Cushman M, Howard VJ, Kabagambe EK. Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr. 2013 May; 97 (5):1121-8 Epub 2013 Apr 03 View PubMed Manne A, Smith I, Hatchett J, Juneau J, Kodali S, Malik TA, Weber FH Jr. Chronic Recurrent Esophageal Diverticulitis - A Rare Entity. Gastroenterology Res. 2013 Feb; 6 (1):37-38 Epub 2013 Mar 09 View PubMed Malik T, Mannon P. Inflammatory bowel diseases: emerging therapies and promising molecular targets. Front Biosci (Schol Ed). 2012 Jan 1; 4:1172-89 Epub 2012 Jan 01 View PubMed Malik TA, Luz LP, Peter S. Caught on camera: an unusual type of bug in the gut. Gastrointest Endosc. 2011 Feb; 73 (2):363-4 Epub 2010 Sept 19 View PubMed Malik TA, Saeed S. Autoimmune hepatitis: a review. J Pak Med Assoc. 2010 May; 60 (5):381-7 View PubMed Malik TA. Immunomodulators are Associated with a Lower Risk of First Surgery among Patients with Non-Penetrating Non-Stricturing CD Am J Gastroenterology. 2009 Nov; 104(11):2754-9. Malik TA. The Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity. Gastroenterology. 2009 Jul. Merchant AT, Lalani I, Afridi ZH, Latif N, Malik TA, Merchant SS, Momin IA, Moizuddin SS, Motiei A, Motiwala S, Munir A, Sethi AK. What is the effect of riskshaw noise on its driver? J Pak Med Assoc. 2000 Apr; 50 (4):124-8 View PubMed PST-20562739 Home Publications